We are live on ! Find out more
ACS

Archford Capital Strategies Portfolio holdings

AUM $987M
1-Year Est. Return 29.31%
This Fund
S&P 500
This Quarter Est. Return
+7.77%
1 Year Est. Return
+29.31%
3 Year Est. Return
+76.21%
5 Year Est. Return
+80.45%
10 Year Est. Return
+551.54%
AUM
$435M
AUM Growth
+$47.5M
Cap. Flow
+$21.7M
Cap. Flow %
5%
Top 10 Hldgs %
25.97%
Holding
298
New
26
Increased
134
Reduced
94
Closed
26

Sector Composition

Rank Sector Weight
1 Technology 12.21%
2 Healthcare 6.63%
3 Financials 5.75%
4 Consumer Staples 4.06%
5 Industrials 3.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TER icon
151
Teradyne
TER
$63B
$704K 0.16%
8,056
-407
-5% -$34.9K
SNY icon
152
Sanofi
SNY
$105B
$698K 0.16%
14,403
+271
+2% +$11.9K
T icon
153
AT&T
T
$166B
$689K 0.16%
37,400
+11,320
+43% +$203K
GILD icon
154
Gilead Sciences
GILD
$168B
$688K 0.16%
8,017
+670
+9% +$53.1K
MMM icon
155
3M
MMM
$94.8B
$685K 0.16%
6,833
+727
+12% +$74.1K
TROW icon
156
T. Rowe Price
TROW
$23.8B
$683K 0.16%
6,265
+2,125
+51% +$240K
MRK icon
157
Merck
MRK
$328B
$681K 0.16%
6,138
+159
+3% +$16.3K
STZ icon
158
Constellation Brands
STZ
$22.9B
$681K 0.16%
2,937
-148
-5% -$35.4K
UBER icon
159
Uber
UBER
$154B
$680K 0.16%
27,503
-4,639
-14% -$127K
RTX icon
160
RTX Corp
RTX
$300B
$679K 0.16%
6,726
-22
-0.3% -$2.07K
O icon
161
Realty Income
O
$59.2B
$674K 0.15%
10,620
-204
-2% -$12.7K
IBDX icon
162
iShares iBonds Dec 2032 Term Corporate ETF
IBDX
$1.73B
$663K 0.15%
+27,410
New +$658K
SPT icon
163
Sprout Social
SPT
$579M
$658K 0.15%
11,650
-10,000
-46% -$587K
GPN icon
164
Global Payments
GPN
$23.4B
$653K 0.15%
+6,570
New +$685K
ABB
165
DELISTED
ABB Ltd
ABB
$648K 0.15%
21,284
+6,590
+45% +$192K
SSNC icon
166
SS&C Technologies
SSNC
$18.8B
$648K 0.15%
+12,441
New +$631K
ZTS icon
167
Zoetis
ZTS
$30.4B
$638K 0.15%
4,356
-216
-5% -$32K
TDIV icon
168
First Trust NASDAQ Technology Dividend Index Fund
TDIV
$4.44B
$630K 0.15%
13,195
+4,273
+48% +$204K
ESGU icon
169
iShares ESG Aware MSCI USA ETF
ESGU
$18.4B
$629K 0.14%
7,423
-46,278
-86% -$3.95M
CVS icon
170
CVS Health
CVS
$121B
$626K 0.14%
6,715
+75
+1% +$7.24K
PACB icon
171
Pacific Biosciences
PACB
$345M
$601K 0.14%
73,479
-9,183
-11% -$79.1K
IWD icon
172
iShares Russell 1000 Value ETF
IWD
$84B
$596K 0.14%
3,933
+646
+20% +$96.7K
CRM icon
173
Salesforce
CRM
$158B
$588K 0.14%
4,433
-303
-6% -$44.2K
WDAY icon
174
Workday
WDAY
$43.3B
$582K 0.13%
3,477
-723
-17% -$113K
PFG icon
175
Principal Financial Group
PFG
$24.4B
$580K 0.13%
6,913
+672
+11% +$57.6K

Similar funds

Archford Capital Strategies's Q4 2022 Portfolio in Review

As of Q4 2022, Archford Capital Strategies held 298 positions worth $435M, up 12% from $387M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Archford Capital Strategies deployed $21.7M of net new capital in Q4 2022, opening 26 new positions and adding to 134 existing holdings. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 126,709 shares worth $10.3M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares Core US Aggregate Bond ETF, an estimated $9.87M trimmed.

  • Archford Capital Strategies's largest Q4 2022 buy was iShares 1-3 Year Treasury Bond ETF: 126,709 shares worth $10.3M.
  • Archford Capital Strategies added most to Vanguard Total Bond Market in Q4 2022, an estimated $10.5M increase.
  • Archford Capital Strategies's biggest Q4 2022 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $9.87M.
  • Archford Capital Strategies fully exited iShares iBonds Dec 2022 Term Corporate ETF in Q4 2022, selling an estimated $3.12M.
  • Archford Capital Strategies's ten largest holdings make up 26% of its $435M portfolio in Q4 2022.
  • Archford Capital Strategies opened 26 new positions and closed 26 in Q4 2022.
  • Archford Capital Strategies's portfolio value rose 12% quarter-over-quarter to $435M.

Based on Archford Capital Strategies's 13F filing for Q4 2022, filed 26 Jan 2023.